News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
303,603 Results
Type
Article (30154)
Company Profile (106)
Press Release (273343)
Section
Business (79736)
Career Advice (285)
Deals (12142)
Drug Delivery (43)
Drug Development (47399)
Employer Resources (38)
FDA (6467)
Job Trends (6481)
News (144046)
Policy (11797)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (3)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (1)
2026 Biotech Bay Standard (1)
Academia (2029)
Academic (1)
Accelerated approval (2)
Adcomms (17)
Allergies (16)
Alliances (24403)
ALS (35)
Alzheimer's disease (645)
Antibody-drug conjugate (ADC) (127)
Approvals (6486)
Artificial intelligence (137)
Autoimmune disease (10)
Automation (4)
Bankruptcy (96)
Best Places to Work (5613)
BIOSECURE Act (15)
Biosimilars (44)
Biotechnology (87)
Bladder cancer (64)
Brain cancer (27)
Breast cancer (273)
Cancer (2115)
Cardiovascular disease (53)
Career advice (264)
Career pathing (7)
CAR-T (132)
Cell therapy (304)
Cervical cancer (21)
Clinical research (37461)
Collaboration (459)
Compensation (149)
Complete response letters (10)
COVID-19 (1353)
CRISPR (22)
C-suite (112)
Cystic fibrosis (33)
Data (1142)
Decentralized trials (1)
Denatured (2)
Depression (5)
Diabetes (67)
Diagnostics (3905)
Digital health (4)
Diversity (4)
Diversity, equity & inclusion (13)
Drug discovery (59)
Drug pricing (44)
Drug shortages (4)
Duchenne muscular dystrophy (19)
Earnings (25432)
Editorial (9)
Employer branding (5)
Employer resources (34)
Events (47626)
Executive appointments (292)
FDA (6988)
Featured Employer (15)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (404)
Gene editing (42)
Generative AI (7)
Gene therapy (119)
GLP-1 (227)
Government (1880)
Guidances (18)
Healthcare (9140)
Huntington's disease (3)
IgA nephropathy (4)
Immunology and inflammation (48)
Indications (16)
Infectious disease (1405)
Inflammatory bowel disease (61)
Inflation Reduction Act (4)
Influenza (16)
Intellectual property (38)
Interviews (29)
IPO (6363)
IRA (23)
Job creations (1130)
Job search strategy (248)
Kidney cancer (10)
Labor market (9)
Layoffs (191)
Leadership (1)
Legal (1974)
Liver cancer (75)
Lung cancer (314)
Lymphoma (128)
Machine learning (2)
Management (11)
Manufacturing (103)
MASH (25)
Medical device (3659)
Medtech (3659)
Mergers & acquisitions (5997)
Metabolic disorders (168)
Multiple sclerosis (21)
NASH (5)
Neurodegenerative disease (18)
Neuropsychiatric disorders (4)
Neuroscience (793)
NextGen: Class of 2025 (2695)
Non-profit (2687)
Northern California (1227)
Now hiring (7)
Obesity (78)
Opinion (96)
Ovarian cancer (75)
Pain (28)
Pancreatic cancer (78)
Parkinson's disease (38)
Partnered (10)
Patents (75)
Patient recruitment (56)
Peanut (10)
People (25582)
Pharmaceutical (23)
Pharmacy benefit managers (4)
Phase I (13509)
Phase II (16464)
Phase III (11394)
Pipeline (565)
Podcasts (21)
Policy (62)
Postmarket research (1314)
Preclinical (5895)
Press Release (28)
Prostate cancer (99)
Psychedelics (13)
Radiopharmaceuticals (235)
Rare diseases (145)
Real estate (1978)
Recruiting (15)
Regulatory (8924)
Reports (17)
Research institute (2080)
Resumes & cover letters (21)
RNA editing (3)
RSV (15)
Schizophrenia (19)
Series A (63)
Series B (30)
Sickle cell disease (31)
Southern California (988)
Special edition (3)
Spinal muscular atrophy (51)
Sponsored (8)
Startups (1772)
State (1)
Stomach cancer (16)
Supply chain (15)
The Weekly (19)
United States (10028)
Vaccines (334)
Venture capitalists (16)
Webinars (3)
Weight loss (37)
Women's health (17)
Worklife (4)
Date
Today (60)
Last 7 days (350)
Last 30 days (1346)
Last 365 days (16671)
2025 (3932)
2024 (17441)
2023 (19753)
2022 (25752)
2021 (27138)
2020 (24549)
2019 (20302)
2018 (15104)
2017 (15126)
2016 (14661)
2015 (17068)
2014 (12825)
2013 (10436)
2012 (10636)
2011 (11039)
2010 (10195)
Location
Africa (295)
Alabama (32)
Alaska (4)
Arizona (75)
Arkansas (5)
Asia (20506)
Australia (3934)
California (2630)
Canada (826)
China (313)
Colorado (116)
Connecticut (128)
Delaware (87)
Europe (42568)
Florida (378)
Georgia (71)
Idaho (20)
Illinois (234)
India (13)
Indiana (131)
Iowa (3)
Japan (73)
Kansas (35)
Kentucky (18)
Louisiana (1)
Maine (12)
Maryland (367)
Massachusetts (1927)
Michigan (47)
Minnesota (131)
Missouri (45)
Montana (14)
Nebraska (9)
Nevada (8)
New Hampshire (39)
New Jersey (884)
New Mexico (11)
New York (894)
North Carolina (334)
North Dakota (4)
Northern California (1227)
Ohio (80)
Oklahoma (6)
Oregon (13)
Pennsylvania (481)
Puerto Rico (3)
Rhode Island (10)
South America (383)
South Carolina (6)
Southern California (988)
Tennessee (25)
Texas (525)
Utah (63)
Virginia (51)
Washington D.C. (39)
Washington State (328)
West Virginia (2)
Wisconsin (34)
303,603 Results for "karmanos cancer institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Karmanos welcomes new VP of the Karmanos Cancer Network
The Barbara Ann Karmanos Cancer Institute has appointed Doris Ranski-Zazula, RN , MSA, as the vice president of the Karmanos Cancer Network, part of McLaren Health Care.
December 5, 2023
·
4 min read
BioMidwest
Karmanos Cancer Institute receives 2024 Women’s Choice Awards® for cancer care and patient experience
The Barbara Ann Karmanos Cancer Institute has been named one of America’s 2024 Best Hospitals for Cancer Care and one of the country’s 100 Best Hospitals for Patient Experience by the Women’s Choice Award®, America’s trusted referral source for the best in health care.
December 20, 2023
·
6 min read
Policy
Karmanos Cancer Institute first to receive new FDA-approved treatment for advanced liver cancer
Karmanos Cancer Institute, the largest provider of cancer care and research in Michigan and part of McLaren Health Care, announced that it will be the first provider in the country to offer patients the new FDA-approved TheraBionic P1 device for the treatment of advanced hepatocellular carcinoma, the most common type of liver cancer.
November 13, 2023
·
5 min read
Drug Development
Karmanos Welcomes Wasif Saif, M.D., to Lead Phase 1 Clinical Trials
The Barbara Ann Karmanos Cancer Institute welcomes Wasif Saif, M.D., MBBS, as the new leader of the Phase 1 Clinical Trials Multidisciplinary Team and co-leader of the Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team.
May 20, 2024
·
5 min read
Business
D’Ambrosio joins Barbara Ann Karmanos Cancer Institute as Chief Development Officer
The Barbara Ann Karmanos Cancer Institute welcomes Arnold D’Ambrosio as the new Chief Development Officer, effective Monday, July 10, 2023.
July 17, 2023
·
5 min read
Business
Stage IV lung cancer survivor, disparities cancer researcher, family physician appointed as Karmanos’ new associate center director
The Barbara Ann Karmanos Cancer Institute welcomes Morhaf Al Achkar, M.D., Ph.D., MSCR, FAAFP, as the associate center director for Education.
November 28, 2023
·
4 min read
Press Releases
Karen Knudsen, MBA PhD, Appointed Chief Executive Officer of the Parker Institute for Cancer Immunotherapy
April 1, 2025
·
7 min read
BioMidwest
Karmanos Cancer Institute invests in software to identify and manage patients at high risk of developing breast cancer
The Barbara Ann Karmanos Cancer Institute, a leading breast cancer prevention and care provider, has adopted Volpara® Risk Pathways™, a market-leading software program designed to simplify risk assessment and patient management for various cancers, including breast, lung, ovarian, and colorectal cancer.
April 11, 2023
·
4 min read
Business
Barbara Ann Karmanos Cancer Institute and Wayne State University name Boris C. Pasche, M.D., Ph.D., FACP, President and Chief Executive Officer
The Barbara Ann Karmanos Cancer Institute, part of Grand Blanc-based McLaren Health Care and a National Cancer Institute -designated Comprehensive Cancer Center, in conjunction with Wayne State University, have named Boris C. Pasche, M.D., Ph.D., FACP, President & Chief Executive Officer and Chair of the Department of Oncology at the Wayne State University School of Medicine.
August 7, 2023
·
7 min read
BioMidwest
Karmanos Cancer Institute reveals the next era of the “Cancer is a Beginning” campaign to inspire recently diagnosed patients across the state
The Barbara Ann Karmanos Cancer Institute kicks off year two of its “Inspired” campaign, inviting the community to view a cancer diagnosis not as an ending but as an opportunity to think bigger, think broader, think “Cancer is a Beginning.”
January 16, 2023
·
4 min read
1 of 30,361
Next